Results 21 to 30 of about 238 (95)

PS1175 DETECTING BCR‐ABL AND SCORING MR: RESULTS FROM A CE‐IVD KIT RUN ON NON‐IVD PCR INSTRUMENTS: A COMPARISON WITH DATA FROM A EUTOS VALIDATED LAB.

open access: yesHemaSphere, Volume 3, Issue S1, Page 534-535, June 2019., 2019
Background: Detection of the BCR‐ABL1 fusion transcript in CML patients using RT‐qPCR allows sensitive monitoring of disease levels (minimal residual disease, MRD), which is important for determining prognosis and making treatment decisions. To interpret MRD results correctly in respect to data from clinical trials, it is necessary to report data as IS,
J. Petersen, G.W. Novotny
wiley   +1 more source

PB1953 QUALITY OF LIFE AND SYMPTOM BURDEN WITH FIRST AND SECOND GENERATION TYROSINE KINASE INHIBITORS IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA

open access: yesHemaSphere, Volume 3, Issue S1, Page 887-888, June 2019., 2019
Background: With the advent of tyrosine kinase inhibitors (TKIs), patients with chronic myeloid leukemia (CML) have a life expectancy similar to those of age‐ and sex‐matched healthy population. Nevertheless, patients receiving TKIs report chronic adverse events, some of which may be associated with severe symptoms including fatigue, edema, muscle ...
T. Toptas   +6 more
wiley   +1 more source

Abstract Book: 25th Congress of the European Hematology Association Virtual Edition, 2020

open access: yes, 2020
HemaSphere, Volume 4, Issue S1, Page 1-1168, June 2020.
wiley   +1 more source

Thymoquinone Induces Downregulation of BCR-ABL/JAK/STAT Pathway and Apoptosis in K562 Leukemia Cells. [PDF]

open access: yesAsian Pac J Cancer Prev, 2021
Al-Rawashde FA   +5 more
europepmc   +1 more source

Poster Sessions

open access: yes
HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Publication Only

open access: yes
HemaSphere, Volume 9, Issue S1, June 2025.
wiley   +1 more source

EHA2024 Hybrid Congress

open access: yes
HemaSphere, Volume 8, Issue S1, June 2024.
wiley   +1 more source

Stem Cell Responsiveness to Imatinib in Chronic Myeloid Leukemia. [PDF]

open access: yesInt J Mol Sci, 2023
Lahlil R   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy